Wednesday, October 28, 2026 | 11:29 AM ISTहिंदी में पढें
Pharma Pricing Issue
Centre to cap trade margins on non-scheduled cancer drugs at 30%
Move could cut MRPs by up to 70%, save patients ₹2,500 crore annually; comes amid SC scrutiny of high mark-ups
 "Centre to cap trade margins on non-scheduled cancer drugs at 30%")
Updated On : 09 Oct 2026 | 12:17 AM IST
Near-term growth issues and cost pressure could impact Aurobindo Pharma
While valuations are now attractive, product approvals and progress on the injectable guidance are among key long-term term triggers
 "Near-term growth issues and cost pressure could impact Aurobindo Pharma")
Updated On : 03 Jun 2022 | 11:33 PM IST
NPPA vs Pharma makers: Industry body knocks Ananth Kumar's door over notice
NPPA issued show-cause notices to leading drug makers over 'suspected overcharging'
 "NPPA vs Pharma makers: Industry body knocks Ananth Kumar's door over notice")
Updated On : 23 May 2017 | 2:50 AM IST